Wednesday - April 30, 2025

Ulcerative Colitis Treatment Market Size in 7MM is expected to grow at a decent CAGR by 2034, estimates DelveInsight

DelveInsight’s “Ulcerative Colitis Market Insights, Epidemiology and Market Forecast – 2034” report delivers an in-depth understanding of the Ulcerative Colitis, historical and forecasted epidemiology as well as the Ulcerative Colitis market trends in the United States, EU4 (Germany, France, Italy, … Continue reading

Aplastic Anemia Treatment Market Size in 7MM is expected to grow at a decent CAGR by 2034, estimates DelveInsight

DelveInsight’s ” Aplastic Anemia Market Insights, Epidemiology, and Market Forecast- 2034” report delivers an in-depth understanding of the Aplastic Anemia, historical and forecasted epidemiology as well as the Aplastic Anemia Market Trends in the United States, EU5 (Germany, Spain, Italy, … Continue reading

Spondylolisthesis Market Growth to Accelerate in Forecast Period (2023-2032), DelveInsight Analyzes | Novadip Biosciences, Ankasa Regenerative Therapeutics, Inc, DePuy Synthes

The Key Spondylolisthesis Companies in the market include – Novadip Biosciences, Ankasa Regenerative Therapeutics, Inc, DePuy Synthes, and others.   DelveInsight’s “Spondylolisthesis Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Spondylolisthesis, historical and forecasted epidemiology … Continue reading

Fabry Disease Market: Epidemiology, Drugs, Companies, DelveInsight | Amicus Therapeutics, CHIESI Farmaceutici and Protalix Biotherapeutics, Sanofi (Genzyme), Takeda Pharmaceuticals, Sangamo Therapeuti

Fabry Disease Market Fabry Disease Emerging drugs such as Venglustat, Lucerastat, and others are expected to boost the Fabry Disease Market in the upcoming years. DelveInsight has launched a new report on “Fabry Disease – Market Insights, Epidemiology, and Market … Continue reading

Hypersomnia Clinical Trials, Drugs, Companies, Hypersomnia Treatment Market, 2025 | Avadel, Centessa Pharmaceuticals (UK) Limited, Takeda

Hypersomnia Pipeline Insights 2025 Hypersomnia Pipeline constitutes 3+ key companies continuously working towards developing 4+ Hypersomnia treatment therapies, analyzes DelveInsight. Hypersomnia Overview: Hypersomnia is a disorder marked by excessive daytime sleepiness, which can greatly disrupt daily activities, productivity, and overall … Continue reading

Idiopathic Inflammatory Myositis Market is Projected to Grow at a CAGR of 21.1% by 2034 | DelveInsight

Idiopathic Inflammatory Myositis Market The idiopathic inflammatory myositis treatment market is poised for significant expansion, driven by the introduction of innovative targeted therapies and increasing disease awareness. Key idiopathic inflammatory myositis companies, including Octapharma, Pfizer, Mitsubishi Tanabe Pharma, AstraZeneca, Priovant … Continue reading